EGI
KURA icon

EAM Global Investors’s Kura Oncology KURA Stock Holding History

EAM Global Investors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-82,159
Closed -$2.68M – 163
2020
Q4 		$2.68M Sell
82,159
-49,597
-38% -$1.74M 0.73% 56
2020
Q3 		$4.04M Buy
+131,756
New +$2.91M 1.48% 6
2018
Q2 		– Sell
-52,885
Closed -$992K – 170
2018
Q1 		$992K Sell
52,885
-23,415
-31% -$456K 0.51% 104
2017
Q4 		$1.17M Buy
+76,300
New +$1.12M 0.6% 56

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM Global Investors's KURA Position: Q1 2021 in Review

EAM Global Investors sold out of Kura Oncology (KURA) in Q1 2021, closing a stake of 82,159 shares — an estimated $2.68M sold.

EAM Global Investors first reported a position in KURA in Q4 2017 and held it in 4 quarters. The position peaked at $4.04M in Q3 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q1 2021.

  • EAM Global Investors reported no remaining Kura Oncology position as of Q1 2021 after selling out during the quarter.
  • EAM Global Investors sold 82,159 Kura Oncology shares in Q1 2021, an estimated $2.68M.
  • EAM Global Investors first reported a position in Kura Oncology in Q4 2017 and held it in 4 quarters.
  • EAM Global Investors's Kura Oncology position peaked at $4.04M in Q3 2020.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2021.

Based on EAM Global Investors's 13F filing for Q1 2021, filed 11 May 2021.